Last reviewed · How we verify
drugs linked with QT-prolongation — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
drugs linked with QT-prolongation (drugs linked with QT-prolongation) — KU Leuven.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| drugs linked with QT-prolongation TARGET | drugs linked with QT-prolongation | KU Leuven | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- drugs linked with QT-prolongation CI watch — RSS
- drugs linked with QT-prolongation CI watch — Atom
- drugs linked with QT-prolongation CI watch — JSON
- drugs linked with QT-prolongation alone — RSS
Cite this brief
Drug Landscape (2026). drugs linked with QT-prolongation — Competitive Intelligence Brief. https://druglandscape.com/ci/drugs-linked-with-qt-prolongation. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab